Protagonist Therapeutics Inc (PTGX) — Cash Flow Reinvestment Rate
Protagonist Therapeutics Inc (PTGX) has a Cash Flow Reinvestment Rate of 0.76x as of March 2025, reinvesting $94.95 Million (capex $545.00K plus investments $-94.40 Million) from operating cash flow of $125.36 Million. Check Protagonist Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Protagonist Therapeutics Inc Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Protagonist Therapeutics Inc across 2 annual periods. Explore Protagonist Therapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Protagonist Therapeutics Inc (2017–2024)
Year-by-year capital reinvestment analysis for Protagonist Therapeutics Inc. For live market cap and broader valuation context, see how much is Protagonist Therapeutics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.63x | $300.84 Million | $184.15 Million | $1.35 Million | ▼ -61.6% |
| 2017 | 4.26x | $16.49 Million | $3.87 Million | $666.00K | — |